{
    "nct_id": "NCT05505643",
    "official_title": "COOL-IT: Cryoablation vs Lumpectomy in T1 Breast Cancers: A Randomized Controlled Trial With Safety Lead-in",
    "inclusion_criteria": "* Diagnosis of invasive ductal carcinoma of the breast of Luminal type A (ER/PR positive, Her-2 negative) that is grade 1 or 2 with intraductal component <25%. Must be T1N0M0 (2 cm or less).\n* Oncotyping will be performed on T1b+Allred<6/8 and T1c tumors. Oncotype score in this subset of patients must be <26 to be included in the trial.\n* At least 50 years of age.\n* Mass must be visible on ultrasound and >5 mm from skin and chest wall muscles.\n* Able to understand and willing to sign an IRB-approved written informed consent document.\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 50 Years",
    "exclusion_criteria": "* Indication for neoadjuvant chemotherapy.\n* Prior history of breast cancer.\n* Breast augmentation.\n* Allergy to local anesthetics.\n* Pregnant or lactating. Women of childbearing potential must have a negative pregnancy test within 14 days of study entry.\n* DCIS present beyond the proposed ablation zone on MRI, mammography, or ultrasound.\n* Positive axillary lymph nodes as assessed by axillary ultrasound, axillary sampling, or axillary sentinel node procedure.",
    "miscellaneous_criteria": ""
}